Rockwell Automation
Rockwell Automation, Inc.
Key figures
Period Oct 2024 to Sep 2025ConsolidatedU.S. GAAP
RevenueDisclosed
US$8.3B
Operating marginCalculated
20.4%
Net assets to total assetsCalculated
32.6%
Company profile
Tables scroll sideways
Disclosed data
Profitability
★★★★☆position among all companies
20.4%
Growth (revenue, 4-year average)
★★★☆☆position among all companies
4.5%
Capital efficiency
★★★★☆position among all companies
23.8%
Revenue and profit
Performance, financial position and capital allocation
Rockwell Automation
Recent performance trends
Rockwell Automation
Cash flow trends
Consolidated indicators (9 items)
| Item | 4 years ago | 3 years ago | 2 years ago | Last year | This year |
|---|---|---|---|---|---|
| Net sales | US$7.0 billion | US$7.8 billion | US$9.1 billion | US$8.3 billion | US$8.3 billion |
| Operating income | Could not be retrieved | Could not be retrieved | US$1.9 billion | US$1.6 billion | US$1.7 billion |
| Net income | US$1.4 billion | US$0.9 billion | US$1.4 billion | US$1.0 billion | US$0.9 billion |
| Total assets | US$10.7 billion | US$10.8 billion | US$11.3 billion | US$11.2 billion | US$11.2 billion |
| Shareholders' equity | US$2.4 billion | US$2.7 billion | US$3.6 billion | US$3.5 billion | US$3.7 billion |
| Net cash provided by (used in) operating activities | US$1.3 billion | US$0.8 billion | US$1.4 billion | US$0.9 billion | US$1.5 billion |
| Net cash provided by (used in) investing activities | US$-2.6 billion | US$-7.80 million | US$0.9 billion | US$-1.0 billion | US$-0.2 billion |
| Net cash provided by (used in) financing activities | US$1.3 billion | US$-0.9 billion | US$-1.7 billion | US$-0.5 billion | US$-1.3 billion |
| Cash and cash equivalents | US$0.7 billion | US$0.5 billion | US$1.1 billion | US$0.5 billion | US$0.5 billion |
Revenue scale in the same industry
Rockwell Automation
Instruments and medical devices: 43 companies · revenue · largest first・each company’s latest fiscal year・Consolidated・Disclosed
- 1 Thermo Fisher ScientificFY Dec 2025 US$44.6B
- 2 Northrop Grumman Corp /DE/FY Dec 2025 US$42.0B
- 3 MedtronicFY Apr 2026 US$36.4B
- … 9 companies
- 13 Baxter InternationalFY Dec 2025 US$11.2B
- 14 Intuitive SurgicalFY Dec 2025 US$10.1B
- 15 Rockwell AutomationThis companyFY Sep 2025 US$8.3B
- 16 SolventumFY Dec 2025 US$8.3B
- 17 Zimmer Biomet HoldingsFY Dec 2025 US$8.2B
- … 26 companies
Sources and methodology
Basic indicators
| Item | Value | Consolidated / Non-consolidated | Source |
|---|---|---|---|
| Purchase of property, plant and equipment | US$0.2 billion | Consolidated | Disclosed |
| Cash and cash equivalents | US$0.5 billion | Consolidated | Disclosed |
| Net cash provided by (used in) financing activities | US$-1.3 billion | Consolidated | Disclosed |
| Net cash provided by (used in) investing activities | US$-0.2 billion | Consolidated | Disclosed |
| Net cash provided by (used in) operating activities | US$1.5 billion | Consolidated | Disclosed |
| Depreciation and amortization | US$0.3 billion | Consolidated | Disclosed |
| Dividends paid | US$0.6 billion | Consolidated | Disclosed |
| Stockholders' equity (including non-controlling interests) | US$3.7 billion | Consolidated | Disclosed |
| Non-controlling interests | US$57.00 million | Consolidated | Disclosed |
| Net assets | US$3.7 billion | Consolidated | Disclosed |
| Net sales | US$8.3 billion | Consolidated | Disclosed |
| Operating income | US$1.7 billion | Consolidated | Disclosed |
| Net income | US$0.9 billion | Consolidated | Disclosed |
| Total assets | US$11.2 billion | Consolidated | Disclosed |
| Purchase of treasury stock | US$0.4 billion | Consolidated | Disclosed |
| Operating margin | 20.4% | Consolidated | Calculated |
| Net assets to total assets | 32.6% | Consolidated | Calculated |
| Net margin | 10.4% | Consolidated | Calculated |
| Return on equity | 23.8% | Consolidated | Calculated |